16-week Flexible vs. 8-week Semaglutide Titration

NCT04447859 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

100

Enrollment

OTHER_GOV

Sponsor class

Conditions

Diabetes type2

Interventions

DRUG: Semaglutide
OTHER: label recommended titration

Sponsor

Tel-Aviv Sourasky Medical Center